DS-7011a

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-7011a, covering 2025-04-04 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DS-7011a in Patients With Systemic Lupus Erythematosus [Phase 1, Phase 2]